Status:
COMPLETED
The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the "Phoenix Sign" Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care
Lead Sponsor:
US Neuropathy Centers
Conditions:
Drop Foot
Eligibility:
All Genders
Phase:
NA
Brief Summary
This pilot study aims to investigate the effects of nerve blocks in patients with diabetic peripheral neuropathy through a double-blinded, randomized trial involving 4 patients. Each participant will ...
Detailed Description
Detailed Analysis of the Phoenix Sign and Vascular Changes Following Nerve Blocks in Diabetic Neuropathy Study Background and Purpose This study investigates the vascular and neurological phenomena ...
Eligibility Criteria
Inclusion
- subjects were included if they were diabetic and neuropathic.
Exclusion
- Patients with Trypanophobia
Key Trial Info
Start Date :
March 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT06919289
Start Date
March 7 2024
End Date
July 1 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana Foot and Ankle
Jasper, Indiana, United States, 47546